Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. 10-Hydroxy-2-Decanoic Acid has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Royal jelly, propolis and honey are formulated together because they come from the same hive rather than because their actions were shown to combine. Anyone reacting to one bee product has a raised chance of reacting to the others. The pairing is convention, and it should be read that way rather than as demonstrated synergy.
10-HDA carries a carbon-carbon double bond next to its carboxyl group, which makes it oxidisable in the way any unsaturated fatty acid is. Tocopherols added to the oil phase interrupt the chain reaction that degrades it. This protects assayed content across shelf life. It is a stability measure, not a biological pairing.
A medium-chain hydroxy fatty acid is poorly soluble in water and disperses badly in an aqueous product. Phospholipid emulsifiers keep it distributed instead of separating out. Formulators use this to hold a uniform dose per serving in liquids and softgels.
Medium-chain triglycerides give a low-viscosity lipid phase that dissolves a C10 hydroxy acid readily. That makes softgel and emulsion dosing practical at small active weights. The carrier does not change what the molecule does, only whether it stays in solution.
Ascorbate at the aqueous interface regenerates the tocopheroxyl radical back to tocopherol, extending how long the lipid-phase antioxidant keeps working. In a royal jelly product with both phases present, that matters for the assayed 10-HDA figure over time. This is formulation chemistry rather than a physiological claim.
Both sit in the medium-chain fatty acid family and follow similar absorption routes into portal circulation. They are chemically distinct, since 10-HDA carries a hydroxyl group and a double bond that caprylic acid does not. Do not read data on one as data on the other. The overlap is in handling, not in identity.
Nothing specific on file for 10-Hydroxy-2-Decanoic Acid. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.